JPMorgan Chase Upgrades Adient to 'Overweight', Sees 33% Upside Potential

Adient (NYSE:ADNT) has received an upgrade from JPMorgan Chase & Co. to an 'overweight' rating, representing a potential upside of 33.26% from its previous close.

The move comes after several other research reports on the company have been released in recent weeks. Barclays reduced their target price on Adient shares from $29.00 to $25.00 and set an 'equal weight' rating, while Zacks Research downgraded Adient from a 'hold' rating to a 'strong sell' rating.

The average rating for Adient among analysts is currently 'hold', with seven investment analysts giving the stock a 'buy' rating, two assigning a 'hold' rating, and three issuing a 'sell' rating. The consensus price target is $26.30.